Aurobindo Pharma Has one of several broadest API portfolios between Indian pharmaceutical businesses, with above 200 APIs. It can be a number one world-wide manufacturer of semi-synthetic penicillins and maintains a strong existence in anti-retrovirals and cardiovascular APIs. The corporate’s vertically built-in model provides sizeable cost pros. Policy alignment is https://www.tjcy.com/industry-information/api-vs-fdf-vs-intermediates-what-s-the-difference.html